Transcranial brain parenchyma sonographic findings in patients with myotonic dystrophy type 1 and 2

Mijajlovic, Milija; Bozovic, Ivo; Pavlovic, Aleksandra; Rakocevic-Stojanovic, Vidosava; Gluscevic, Sanja; Stojanovic, Amalija; Basta, Ivana; Meola, Giovanni; Peric, Stojan

doi:10.1016/j.heliyon.2024.e26856

Heliyon

2024

DOI: 10.1016/j.heliyon.2024.e26856

|View full text |Cite

Transcranial brain parenchyma sonographic findings in patients with myotonic dystrophy type 1 and 2

Milija Mijajlovic,

Ivo Bozovic,

Aleksandra Pavlovic

et al.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2024

Publication Types

Select...

Article1

Relationship

Self Cite0

Independent1

Authors

Journals

Cited by 1 publication

References 53 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

Myotonic dystrophies: an update on clinical features, molecular mechanisms, management, and gene therapy

Rimoldi,

Lucchiari,

Pagliarani

et al. 2024

Neurol Sci

View full text Add to dashboard Cite

Myotonic dystrophies (DM) encompass a group of complex genetic disorders characterized by progressive muscle weakness with myotonia and multisystemic involvement. The aim of our paper is to synthesize key findings and advancements in the understanding of DM, and to underline the multidisciplinary approach to DM, emphasizing the importance of genetic counseling, comprehensive clinical care, and symptom management. We discuss the genetic basis of DM, emphasizing the role of repeat expansions in disease pathogenesis, as well as cellular and animal models utilized for studying DM mechanisms and testing potential therapies. Diagnostic challenges, such as determining the size of disease expansions and assessing mosaicism, are elucidated alongside emerging genetic testing methods. Therapeutic strategies, mainly for DM1, are also explored, encompassing small molecules, nucleic acid-based therapies (NATs), and genome/transcriptome engineering. The challenges of such a therapeutic delivery and immunogenic response and the importance of innovative strategies, including viral vectors and AAV serotypes, are highlighted within the text. While no curative treatments have been approved, supportive and palliative care remains essential, with a focus on addressing multisystemic complications and maintaining functional independence. Continued exploration of these therapeutic advancements offers hope for comprehensive disease management and potentially curative therapies for DM1 and related disorders.

show abstract

Myotonic dystrophies: an update on clinical features, molecular mechanisms, management, and gene therapy

Rimoldi,

Lucchiari,

Pagliarani

et al. 2024

Neurol Sci

View full text Add to dashboard Cite

show abstract

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Transcranial brain parenchyma sonographic findings in patients with myotonic dystrophy type 1 and 2

Cited by 1 publication

References 53 publications

Myotonic dystrophies: an update on clinical features, molecular mechanisms, management, and gene therapy

Myotonic dystrophies: an update on clinical features, molecular mechanisms, management, and gene therapy

Contact Info

Product

Resources

About